nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirenzepine—Trifluoperazine—TNNC1—dilated cardiomyopathy	0.217	0.38	CrCbGaD
Pirenzepine—Oxcarbazepine—SCN5A—dilated cardiomyopathy	0.194	0.34	CrCbGaD
Pirenzepine—Mirtazapine—ADRB1—dilated cardiomyopathy	0.066	0.116	CrCbGaD
Pirenzepine—Mirtazapine—ADRB2—dilated cardiomyopathy	0.0555	0.0971	CrCbGaD
Pirenzepine—Loxapine—ADRB1—dilated cardiomyopathy	0.0385	0.0674	CrCbGaD
Pirenzepine—CHRM5—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0205	0.0479	CbGpPWpGaD
Pirenzepine—CHRM5—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0172	0.0403	CbGpPWpGaD
Pirenzepine—CHRM5—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.0166	0.0388	CbGpPWpGaD
Pirenzepine—CHRM1—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0144	0.0337	CbGpPWpGaD
Pirenzepine—CHRM5—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.014	0.0326	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0133	0.0311	CbGpPWpGaD
Pirenzepine—CHRM5—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.013	0.0303	CbGpPWpGaD
Pirenzepine—CHRM5—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.0126	0.0295	CbGpPWpGaD
Pirenzepine—CHRM1—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0121	0.0283	CbGpPWpGaD
Pirenzepine—CHRM1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.0117	0.0273	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0105	0.0244	CbGpPWpGaD
Pirenzepine—CHRM1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00984	0.023	CbGpPWpGaD
Pirenzepine—CHRM5—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00958	0.0224	CbGpPWpGaD
Pirenzepine—CHRM1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00915	0.0213	CbGpPWpGaD
Pirenzepine—CHRM1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.0089	0.0208	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00737	0.0172	CbGpPWpGaD
Pirenzepine—CHRM1—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00674	0.0157	CbGpPWpGaD
Pirenzepine—CHRM5—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00614	0.0143	CbGpPWpGaD
Pirenzepine—CHRM5—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00507	0.0118	CbGpPWpGaD
Pirenzepine—CHRM5—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00498	0.0116	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0044	0.0103	CbGpPWpGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00438	0.0102	CbGpPWpGaD
Pirenzepine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00433	0.0101	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00409	0.00954	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00396	0.00924	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00391	0.00913	CbGpPWpGaD
Pirenzepine—CHRM5—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00386	0.00902	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00377	0.00879	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00377	0.00879	CbGpPWpGaD
Pirenzepine—CHRM1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00357	0.00833	CbGpPWpGaD
Pirenzepine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.0035	0.00818	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0035	0.00818	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00339	0.00792	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00338	0.00789	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00321	0.00749	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0031	0.00723	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00308	0.00719	CbGpPWpGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00308	0.00719	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.0029	0.00676	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00288	0.00672	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00287	0.0067	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00287	0.0067	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00279	0.00651	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00276	0.00643	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00275	0.00643	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00275	0.00642	CbGpPWpGaD
Pirenzepine—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00272	0.00635	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00267	0.00623	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00265	0.00619	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00265	0.00619	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00258	0.00603	CbGpPWpGaD
Pirenzepine—CHRM5—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00256	0.00598	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00247	0.00576	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00239	0.00558	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00238	0.00556	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00226	0.00527	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00221	0.00515	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00218	0.0051	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00217	0.00506	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00209	0.00489	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00204	0.00476	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00204	0.00476	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00202	0.00472	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00202	0.00472	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00194	0.00452	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00194	0.00452	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00191	0.00446	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00188	0.00438	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00182	0.00425	CbGpPWpGaD
Pirenzepine—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.0018	0.00421	CbGpPWpGaD
Pirenzepine—CHRM5—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00176	0.0041	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00162	0.00378	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00162	0.00378	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00155	0.00363	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00155	0.00362	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00151	0.00352	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00147	0.00344	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00147	0.00344	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00147	0.00344	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00146	0.00341	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00144	0.00335	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00137	0.0032	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00135	0.00314	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00133	0.00309	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00131	0.00306	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00125	0.00291	CbGpPWpGaD
Pirenzepine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00124	0.00289	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00118	0.00276	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00114	0.00266	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00114	0.00266	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00113	0.00264	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00109	0.00255	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00107	0.00251	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00106	0.00248	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00104	0.00242	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00104	0.00242	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00103	0.0024	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00098	0.00229	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000964	0.00225	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000934	0.00218	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000923	0.00215	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000918	0.00214	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000878	0.00205	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000877	0.00205	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00087	0.00203	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00087	0.00203	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000834	0.00195	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000833	0.00194	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000809	0.00189	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000797	0.00186	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000797	0.00186	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000783	0.00183	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000756	0.00177	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00069	0.00161	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000669	0.00156	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000647	0.00151	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000635	0.00148	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000618	0.00144	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000613	0.00143	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000613	0.00143	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000587	0.00137	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000569	0.00133	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000561	0.00131	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000553	0.00129	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000551	0.00129	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000545	0.00127	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000493	0.00115	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000471	0.0011	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	0.000471	0.0011	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000447	0.00104	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000389	0.000909	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000384	0.000896	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000379	0.000885	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000347	0.00081	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000331	0.000774	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000327	0.000762	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000267	0.000623	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00023	0.000537	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000224	0.000523	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000158	0.000368	CbGpPWpGaD
